日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/01/17 | 5,900 | 5,920 | 5,760 | 5,760 | -130 | -2.2% | 223,100 |
| 2017/01/16 | 5,860 | 5,930 | 5,830 | 5,890 | -20 | -0.3% | 136,700 |
| 2017/01/13 | 5,800 | 5,920 | 5,800 | 5,910 | +140 | +2.4% | 172,000 |
| 2017/01/12 | 5,900 | 5,900 | 5,730 | 5,770 | -210 | -3.5% | 531,100 |
| 2017/01/11 | 6,000 | 6,000 | 5,900 | 5,980 | +50 | +0.8% | 136,300 |
| 2017/01/10 | 6,120 | 6,120 | 5,890 | 5,930 | -60 | -1% | 224,100 |
| 2017/01/06 | 5,910 | 6,050 | 5,860 | 5,990 | +130 | +2.2% | 317,700 |
| 2017/01/05 | 5,830 | 5,870 | 5,770 | 5,860 | +80 | +1.4% | 158,200 |
| 2017/01/04 | 5,790 | 5,850 | 5,730 | 5,780 | +20 | +0.3% | 210,800 |
| 2016/12/30 | 5,680 | 5,770 | 5,640 | 5,760 | +110 | +1.9% | 181,000 |
| 2016/12/29 | 5,740 | 5,750 | 5,610 | 5,650 | -90 | -1.6% | 149,000 |
| 2016/12/28 | 5,740 | 5,800 | 5,730 | 5,740 | -20 | -0.3% | 111,700 |
| 2016/12/27 | 5,680 | 5,810 | 5,670 | 5,760 | +60 | +1.1% | 179,000 |
| 2016/12/26 | 5,680 | 5,730 | 5,640 | 5,700 | +80 | +1.4% | 109,300 |
| 2016/12/22 | 5,520 | 5,640 | 5,520 | 5,620 | +100 | +1.8% | 272,600 |
| 2016/12/21 | 5,630 | 5,650 | 5,500 | 5,520 | -140 | -2.5% | 202,200 |
| 2016/12/20 | 5,640 | 5,680 | 5,620 | 5,660 | ±0 | ±0% | 134,600 |
| 2016/12/19 | 5,620 | 5,680 | 5,590 | 5,660 | -50 | -0.9% | 215,000 |
| 2016/12/16 | 5,700 | 5,730 | 5,660 | 5,710 | +80 | +1.4% | 190,500 |
| 2016/12/15 | 5,690 | 5,700 | 5,480 | 5,630 | -30 | -0.5% | 173,800 |
| 2016/12/14 | 5,660 | 5,750 | 5,630 | 5,660 | ±0 | ±0% | 188,600 |
| 2016/12/13 | 5,520 | 5,670 | 5,480 | 5,660 | +180 | +3.3% | 222,800 |
| 2016/12/12 | 5,390 | 5,490 | 5,350 | 5,480 | +110 | +2% | 228,200 |
| 2016/12/09 | 5,290 | 5,420 | 5,160 | 5,370 | -20 | -0.4% | 448,300 |
| 2016/12/08 | 5,690 | 5,690 | 5,340 | 5,390 | -200 | -3.6% | 321,800 |
| 2016/12/07 | 5,600 | 5,620 | 5,560 | 5,590 | -80 | -1.4% | 243,800 |
| 2016/12/06 | 5,450 | 5,710 | 5,440 | 5,670 | +310 | +5.8% | 600,600 |
| 2016/12/05 | 5,220 | 5,400 | 5,220 | 5,360 | +80 | +1.5% | 270,400 |
| 2016/12/02 | 5,220 | 5,340 | 5,220 | 5,280 | -40 | -0.8% | 174,600 |
| 2016/12/01 | 5,330 | 5,400 | 5,270 | 5,320 | ±0 | ±0% | 249,600 |
| 2016/11/30 | 5,360 | 5,360 | 5,310 | 5,320 | -60 | -1.1% | 189,700 |
| 2016/11/29 | 5,370 | 5,420 | 5,360 | 5,380 | -30 | -0.6% | 144,200 |
| 2016/11/28 | 5,400 | 5,510 | 5,340 | 5,410 | -50 | -0.9% | 268,600 |
| 2016/11/25 | 5,390 | 5,510 | 5,380 | 5,460 | +130 | +2.4% | 344,000 |
| 2016/11/24 | 5,450 | 5,450 | 5,320 | 5,330 | -30 | -0.6% | 198,200 |
| 2016/11/22 | 5,310 | 5,380 | 5,290 | 5,360 | +20 | +0.4% | 185,300 |
| 2016/11/21 | 5,350 | 5,390 | 5,320 | 5,340 | +20 | +0.4% | 147,000 |
| 2016/11/18 | 5,450 | 5,450 | 5,220 | 5,320 | -60 | -1.1% | 167,900 |
| 2016/11/17 | 5,330 | 5,420 | 5,310 | 5,380 | +40 | +0.7% | 203,600 |
| 2016/11/16 | 5,310 | 5,370 | 5,240 | 5,340 | +190 | +3.7% | 313,500 |
| 2016/11/15 | 5,320 | 5,320 | 5,090 | 5,150 | -150 | -2.8% | 324,700 |
| 2016/11/14 | 5,540 | 5,540 | 5,270 | 5,300 | -190 | -3.5% | 305,800 |
| 2016/11/11 | 5,400 | 5,570 | 5,270 | 5,490 | +120 | +2.2% | 506,700 |
| 2016/11/10 | 5,200 | 5,400 | 5,130 | 5,370 | +440 | +8.9% | 388,700 |
| 2016/11/09 | 5,200 | 5,270 | 4,790 | 4,930 | -160 | -3.1% | 323,200 |
| 2016/11/08 | 5,130 | 5,180 | 5,020 | 5,090 | -50 | -1% | 138,600 |
| 2016/11/07 | 5,230 | 5,230 | 5,090 | 5,140 | -10 | -0.2% | 147,200 |
| 2016/11/04 | 5,200 | 5,230 | 5,090 | 5,150 | -90 | -1.7% | 161,400 |
| 2016/11/02 | 5,290 | 5,330 | 5,180 | 5,240 | -60 | -1.1% | 206,200 |
| 2016/11/01 | 5,290 | 5,360 | 5,270 | 5,300 | -30 | -0.6% | 162,800 |
2051～
2100
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
